» Articles » PMID: 20460467

Global Mapping of Binding Sites for Nrf2 Identifies Novel Targets in Cell Survival Response Through ChIP-Seq Profiling and Network Analysis

Overview
Specialty Biochemistry
Date 2010 May 13
PMID 20460467
Citations 425
Authors
Affiliations
Soon will be listed here.
Abstract

The Nrf2 (nuclear factor E2 p45-related factor 2) transcription factor responds to diverse oxidative and electrophilic environmental stresses by circumventing repression by Keap1, translocating to the nucleus, and activating cytoprotective genes. Nrf2 responses provide protection against chemical carcinogenesis, chronic inflammation, neurodegeneration, emphysema, asthma and sepsis in murine models. Nrf2 regulates the expression of a plethora of genes that detoxify oxidants and electrophiles and repair or remove damaged macromolecules, such as through proteasomal processing. However, many direct targets of Nrf2 remain undefined. Here, mouse embryonic fibroblasts (MEF) with either constitutive nuclear accumulation (Keap1(-/-)) or depletion (Nrf2(-/-)) of Nrf2 were utilized to perform chromatin-immunoprecipitation with parallel sequencing (ChIP-Seq) and global transcription profiling. This unique Nrf2 ChIP-Seq dataset is highly enriched for Nrf2-binding motifs. Integrating ChIP-Seq and microarray analyses, we identified 645 basal and 654 inducible direct targets of Nrf2, with 244 genes at the intersection. Modulated pathways in stress response and cell proliferation distinguish the inducible and basal programs. Results were confirmed in an in vivo stress model of cigarette smoke-exposed mice. This study reveals global circuitry of the Nrf2 stress response emphasizing Nrf2 as a central node in cell survival response.

Citing Articles

Antioxidant-Rich Functional Foods and Exercise: Unlocking Metabolic Health Through Nrf2 and Related Pathways.

Tkaczenko H, Kurhaluk N Int J Mol Sci. 2025; 26(3).

PMID: 39940866 PMC: 11817741. DOI: 10.3390/ijms26031098.


Nrf2 Regulates Basal Glutathione Production in Astrocytes.

He J, Hewett S Int J Mol Sci. 2025; 26(2).

PMID: 39859401 PMC: 11765531. DOI: 10.3390/ijms26020687.


Targeting the Interplay Between Autophagy and the Nrf2 Pathway in Parkinson's Disease with Potential Therapeutic Implications.

Liu M, Liu S, Lin Z, Chen X, Jiao Q, Du X Biomolecules. 2025; 15(1).

PMID: 39858542 PMC: 11764135. DOI: 10.3390/biom15010149.


Modulation of Nrf2 expression by targeting i-motif DNA.

Warner E, Guneri D, OConnell M, MacDonald C, Waller Z Commun Chem. 2025; 8(1):5.

PMID: 39762580 PMC: 11704350. DOI: 10.1038/s42004-024-01387-w.


Anticarcinogenic effects of ursodeoxycholic acid in pancreatic adenocarcinoma cell models.

Kovacs P, Schwarcz S, Nyerges P, Biro T, Ujlaki G, Bai P Front Cell Dev Biol. 2024; 12:1487685.

PMID: 39723238 PMC: 11668698. DOI: 10.3389/fcell.2024.1487685.


References
1.
Thimmulappa R, Lee H, Rangasamy T, Reddy S, Yamamoto M, Kensler T . Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest. 2006; 116(4):984-95. PMC: 1421348. DOI: 10.1172/JCI25790. View

2.
Reddy N, Kleeberger S, Bream J, Fallon P, Kensler T, Yamamoto M . Genetic disruption of the Nrf2 compromises cell-cycle progression by impairing GSH-induced redox signaling. Oncogene. 2008; 27(44):5821-32. PMC: 2646365. DOI: 10.1038/onc.2008.188. View

3.
Singh A, Misra V, Thimmulappa R, Lee H, Ames S, Hoque M . Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer. PLoS Med. 2006; 3(10):e420. PMC: 1584412. DOI: 10.1371/journal.pmed.0030420. View

4.
Yamamoto T, Suzuki T, Kobayashi A, Wakabayashi J, Maher J, Motohashi H . Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Mol Cell Biol. 2008; 28(8):2758-70. PMC: 2293100. DOI: 10.1128/MCB.01704-07. View

5.
Mann G, Niehueser-Saran J, Watson A, Gao L, Ishii T, de Winter P . Nrf2/ARE regulated antioxidant gene expression in endothelial and smooth muscle cells in oxidative stress: implications for atherosclerosis and preeclampsia. Sheng Li Xue Bao. 2007; 59(2):117-27. View